Will I feel the medication wear off before my next weekly injection
After treatment initiation, anticipate gradual weight loss coupled with lifestyle adjustments for optimal results and sustained health benefits
More serious potential adverse effects include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), acute kidney injury (especially with dehydration), and increased risk of hypoglycemia when used with insulin or sulfonylureas
By comparison, the STEP 1 trial for semaglutide reported 14.9% at 68 weeks, and SURMOUNT-1 for tirzepatide reported 20.9% at 72 weeks
More people need treatment for obesity: The rise in obesity rates parallels the rise in GLP-1 prescriptions
This puts people at a higher risk for problems, from small side effects to big health issues